Status:
COMPLETED
Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses
Lead Sponsor:
The Dial Corporation
Collaborating Sponsors:
Hill Top Research
TKL Research, Inc.
Conditions:
Common Cold
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy of 3804-250A in the prevention of the common cold. The study will also evaluate whether 3804-250A prevents rhinovirus infection, a virus that caus...
Detailed Description
Rhinovirus infections are the most frequent cause up to 80% of cold illnesses during the fall rhinovirus season. While viral upper respiratory infections are generally mild and self-limited, they are ...
Eligibility Criteria
Inclusion
- healthy normal
- good general health
Exclusion
- pregnancy
- insulin dependent diabetes
- daily smoker
- skin disease on the hands/wrists
- immunological disorders
- occupation involving frequent handwashing
- common cold symptoms
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT00762476
Start Date
August 1 2008
End Date
November 1 2008
Last Update
April 16 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
TKL Research, Inc.
Paramus, New Jersey, United States, 07652
2
University of Virginia School of Medicine
Charlottesville, Virginia, United States, 22908